HealthStream, Inc. (NASDAQ:HSTM - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the five ratings firms that are covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation, two have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is $32.00.
A number of research firms have recently weighed in on HSTM. Canaccord Genuity Group increased their price target on HealthStream from $29.00 to $30.00 and gave the stock a "hold" rating in a report on Wednesday, February 26th. JMP Securities reiterated a "market perform" rating on shares of HealthStream in a research report on Thursday, February 6th. Finally, William Blair restated an "outperform" rating on shares of HealthStream in a report on Tuesday, February 25th.
Check Out Our Latest Stock Analysis on HealthStream
HealthStream Trading Up 0.3 %
HSTM stock traded up $0.10 during trading on Friday, reaching $32.28. 143,883 shares of the stock were exchanged, compared to its average volume of 129,713. The firm has a market capitalization of $982.41 million, a price-to-earnings ratio of 49.66, a P/E/G ratio of 4.37 and a beta of 0.37. The business has a 50 day moving average price of $32.61 and a 200-day moving average price of $31.44. HealthStream has a 1 year low of $23.92 and a 1 year high of $34.24.
HealthStream (NASDAQ:HSTM - Get Free Report) last released its quarterly earnings results on Monday, February 24th. The technology company reported $0.16 EPS for the quarter, beating the consensus estimate of $0.13 by $0.03. The firm had revenue of $74.24 million for the quarter, compared to analyst estimates of $73.55 million. HealthStream had a net margin of 6.84% and a return on equity of 5.67%. During the same quarter in the previous year, the company earned $0.14 EPS. On average, research analysts anticipate that HealthStream will post 0.63 EPS for the current year.
HealthStream Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Monday, March 10th were given a $0.031 dividend. This is an increase from HealthStream's previous quarterly dividend of $0.03. This represents a $0.12 annualized dividend and a yield of 0.38%. The ex-dividend date of this dividend was Monday, March 10th. HealthStream's payout ratio is currently 18.18%.
Institutional Trading of HealthStream
Several hedge funds have recently made changes to their positions in HSTM. Connor Clark & Lunn Investment Management Ltd. increased its stake in HealthStream by 81.0% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 38,615 shares of the technology company's stock worth $1,114,000 after buying an additional 17,286 shares during the period. Charles Schwab Investment Management Inc. raised its stake in shares of HealthStream by 3.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 218,447 shares of the technology company's stock valued at $6,300,000 after acquiring an additional 6,832 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in HealthStream in the third quarter valued at $269,000. FMR LLC grew its stake in HealthStream by 24.0% during the 3rd quarter. FMR LLC now owns 119,067 shares of the technology company's stock worth $3,434,000 after purchasing an additional 23,055 shares in the last quarter. Finally, BNP Paribas Financial Markets increased its holdings in HealthStream by 36.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 15,945 shares of the technology company's stock worth $460,000 after purchasing an additional 4,257 shares during the period. Institutional investors and hedge funds own 69.58% of the company's stock.
About HealthStream
(
Get Free ReportHealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
See Also

Before you consider HealthStream, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthStream wasn't on the list.
While HealthStream currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.